ReadHealthy Communications to Sponsor 2024 BIO CEO & Investor Conference

The conference sponsorship marks the conclusion of ReadHealthy Communications' inaugural year of business and sets the stage for exponential growth in year two.

LIVINGSTON, N.J., Feb. 19, 2024 /PRNewswire-PRWeb/ -- ReadHealthy Communications, LLC, a public relations and corporate communications firm that helps life sciences companies identify, solidify, and amplify their stories, announced today that it will sponsor the upcoming 2024 BIO CEO & Investor Conference, to be held February 26 - 27 in New York City. The annual conference, hosted by the Biotechnology Innovation Organization (BIO), focuses on emerging biotech companies—both private and public—that will drive the next generation of biotech breakthroughs.

In addition to sponsorship, ReadHealthy Communications' founder and CEO Jennifer Ringler will be attending the event and accepting meetings with pharma/biotech, med tech, and digital health companies to discuss strategies and opportunities for those companies to increase brand awareness and credibility through marketing and public relations.

"I'm so thrilled to be attending and sponsoring the BIO CEO & Investor event," says Ringler. "As ReadHealthy Communications approaches its one-year anniversary on March 1, being part of such a successful industry event feels like the culmination of everything we've worked for and achieved in our first year. We're incredibly excited for year two."

ReadHealthy Communications offers a full spectrum of communications services for biotech, pharma, digital health, med device, and other companies working in the healthcare industry. The agency's areas of expertise include corporate and brand narratives, thought leadership content, scientific storytelling and regulatory milestones, marketing, media relations, digital/social content and strategy, and more. The company focuses on the importance of compelling storytelling, helping its clients reach a varied audience of stakeholders, including healthcare professionals, hospital leaders, payers, investors, and patients.

Ringler brings more than 13 years of experience to her role as founder & CEO. She began her health communications career in 2010 as a reporter for Pharmaceutical Executive magazine and spent several years in writing and editing roles for industry trade publications, consumer health magazines, and nonprofits. In 2013, Ringler earned her Master of Science in Health Communication and transitioned from journalism to marketing and PR. Her bylines have been published in Pharmaceutical Executive, Life Science Leader, Chief Healthcare Executive, PRNews, and more. Her autobiographical essay about growing up visually impaired and later working at a summer program for the blind and visually impaired was published in the university textbook, "Racism and Sexism: A Collaborative Study," by Kendall Hunt Publishing, in 2004. Ringler currently serves on the board of directors for the nonprofit STEMM & Cancer Healthy Equity Foundation.

"Jennifer has played an indispensable role in reshaping our company's communications strategy," says ReadHealthy Communications client Nathalya Mamane, founder & CEO of home diagnostics company RT MicroDx. "With a deep understanding of our mission and voice, she has not only elevated our messaging but has also become a true extension of our team. Her dedication to excellence is evident in every piece of work, which has set us on a path to greater success."

Those seeking to schedule a meeting with ReadHealthy Communications during or after the upcoming BIO CEO & Investor Conference can email [email protected].

About ReadHealthy Communications, LLC

ReadHealthy Communications, LLC, is a woman owned, disability-owned public relations and corporate communications firm that helps healthcare and life sciences companies identify, solidify, and amplify their stories. With deep roots in scientific storytelling and healthcare journalism, we partner with pharmaceutical, biotech, and medical device companies for corporate communications, marketing, media relations, and more. Whether you're looking to reach C-suite decision makers, legislators, healthcare providers, investors, payers, or patients, we make your health and life sciences stories matter to the stakeholders that matter to you. Because your stories matter. Your stories are changing the world. Discover more at http://www.readhealthy.net.

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial, and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

Media Contact

Jennifer Ringler, MS, ReadHealthy Communications, 1 973-647-5004, [email protected], https://www.readhealthy.net/

View original content to download multimedia:https://www.prweb.com/releases/readhealthy-communications-to-sponsor-2024-bio-ceo--investor-conference-302063853.html

SOURCE ReadHealthy Communications